Stefan K. Barta

Hospital of the University of Pennsylvania

Also affiliated with UPMC Hillman Cancer Center, University of Pennsylvania

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 20 papers. Top paper: “Ipilimumab, nivolumab, and brentuximab vedotin combination therapies in patients with relapsed or refractory Hodgkin lymphoma: phase 1 results of an open-label, multicentre, phase 1/2 trial”.

Ipilimumab, nivolumab, and brentuximab vedotin combination therapies in patients with relapsed or refractory Hodgkin lymphoma: phase 1 results of an open-label, multicentre, phase 1/2 trial

The Lancet Haematology(2020)10.1016/s2352-3026(20)30221-0

N/A

3.3DataRank · unranked

142 citations

Fangxin Hong, Richard F. Ambinder, Jonathon B. Cohen, Michael J. Robertson, Kevin A. David +12 more

Brentuximab vedotin with AVD for stage II–IV HIV-related Hodgkin lymphoma (AMC 085): phase 2 results from an open-label, single arm, multicentre phase 1/2 trial

The Lancet Haematology(2023)10.1016/s2352-3026(23)00157-6

N/A

0.847DataRank · unranked

32 citations

Page C. Moore, Milan Bimali, Jeanette Y. Lee, Michelle A. Rudek, Amy Chadburn +22 more

A20 and RBX1 Regulate Brentuximab Vedotin Sensitivity in Hodgkin Lymphoma Models

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-4137

N/A

0DataRank · unranked

27 citations

Yuquan Lin, Zhihui Song, Wenming Xiao, Liqi Chen, Jiejing Yin +6 more

Older patients with mantle cell lymphoma (MCL): Practice patterns and predictors of survival in the rituximab era.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.e20064

N/A

0DataRank · unranked

0 citations

Jeffrey M. Switchenko, Subir Goyal, Veronika Bachanová, James N. Gerson, Stefan K. Barta +15 more

Early relapse identifies MCL patients with inferior survival after intensive or less intensive frontline therapy

Blood Advances(2021)10.1182/bloodadvances.2021004765

N/A

0DataRank · unranked

41 citations

Jeffrey M. Switchenko, Diego Villa, Kami J. Maddocks, Michael C. Churnetski, Alina S. Gerrie +30 more

Genetic subgroups inform on pathobiology in adult and pediatric Burkitt lymphoma

Blood(2022)10.1182/blood.2022016534

N/A

0DataRank · unranked

88 citations

Kostiantyn Dreval, Daniela S. Gerhard, Laura K. Hilton, Jeremy S. Abramson, Richard F. Ambinder +63 more

Impact of diagnosis to treatment interval in patients with newly diagnosed mantle cell lymphoma

Blood Advances(2022)10.1182/bloodadvances.2022009225

N/A

0DataRank · unranked

11 citations

Jeffrey M. Switchenko, Veronika Bachanová, James N. Gerson, Stefan K. Barta, Max J. Gordon +30 more

Advances and Personalized Approaches in the Frontline Treatment of T-Cell Lymphomas

Journal of Personalized Medicine(2022)10.3390/jpm12020267

N/A

0DataRank · unranked

6 citations

Hatcher J. Ballard, Stefan K. Barta, Mathew G. Angelos

Alliance A059102: A randomized phase II U.S. intergroup study of CHO(E)P versus CC-486-CHO(E)P versus duvelisib-CHO(E)P in previously untreated, CD30-negative, peripheral T-cell lymphomas.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.tps7593

N/A

0DataRank · unranked

4 citations

Susan M. Geyer, Stefan K. Barta, Jennifer E. Amengual, Travis Dockter, Chadwick Wright +8 more

Central Nervous System Progression/Relapse in Mature T- and NK-Cell Lymphomas

Cancers(2023)10.3390/cancers15030925

N/A

0DataRank · unranked

7 citations

Stefan K. Barta, Rahul S. Bhansali

SOHO State of the Art Updates and Next Questions | Challenging Cases in Rare T-Cell Lymphomas

Clinical Lymphoma Myeloma & Leukemia(2023)10.1016/j.clml.2023.05.012

N/A

0DataRank · unranked

7 citations

Stefan K. Barta, Rahul S. Bhansali

Immunologic predictors of vaccine responsiveness in patients with lymphoma and CLL

medRxiv(2023)10.1101/2023.09.26.23295903

N/A

0DataRank · unranked

0 citations

Kingsley Gideon Kumashie, Emeline R. Chong, Joseph Fabrizio, Aditi Gupta, Jakub Svoboda +38 more

CD5 deletion enhances the antitumor activity of adoptive T cell therapies

Science Immunology(2024)10.1126/sciimmunol.adn6509

N/A

0DataRank · unranked

48 citations

Guido Ghilardi, Yunlin Zhang, Yi‐Hao Chiang, Wei Xie, Puneeth Guruprasad +46 more

Immunotherapy-resistant acute lymphoblastic leukemia cells exhibit reduced CD19 and CD22 expression and BTK pathway dependency

Journal of Clinical Investigation(2024)10.1172/jci175199

N/A

0DataRank · unranked

20 citations

Orsi Giricz, David T. Melnekoff, R. Alejandro Sica, Veronika Polishchuk, Cristian Papazoglu +22 more

Efficacy and safety of bendamustine for lymphodepletion before lisocabtagene maraleucel

Journal of Hematology & Oncology(2024)10.1186/s13045-024-01542-9

N/A

0DataRank · unranked

11 citations

Luca Paruzzo, Vrutti Patel, Jakub Svoboda, Emeline R. Chong, Eugenio Fardella +15 more

Immunologic Predictors of Vaccine Responsiveness in Patients With Lymphoma and Chronic Lymphocytic Leukemia

The Journal of Infectious Diseases(2024)10.1093/infdis/jiae106

N/A

0DataRank · unranked

5 citations

Kingsley Gideon Kumashie, Emeline R. Chong, Joseph Fabrizio, Aditi Gupta, Jakub Svoboda +38 more

The CNS relapse in T-cell lymphoma index predicts CNS relapse in patients with T- and NK-cell lymphomas

Blood Advances(2024)10.1182/bloodadvances.2024012800

N/A

0DataRank · unranked

4 citations

Fredrik Ellin, Thomas Relander, Miao Cao, Wenrui Li, Qi Long +46 more

Prognosis and Treatment of Plasmablastic Lymphoma in the United States: A Multicenter Retrospective Study

Research Square(2025)10.21203/rs.3.rs-7607922/v1

N/A

0DataRank · unranked

0 citations

Brian L. Egleston, Zachary AK Frosch, Ralphael Steiner, Ariela Noy, Veronica Carvajal +42 more

Comparative effectiveness of immunotherapy alone or with chemotherapy as first-line treatment for marginal zone lymphoma

Haematologica(2025)10.3324/haematol.2025.288946

N/A

0DataRank · unranked

0 citations

Thomas Ollila, Dai Chihara, Geoffrey Shouse, Natalie S. Grover, Reem Karmali +7 more

Ibrutinib-associated Arthralgias/Myalgias in Patients With Chronic Lymphocytic Leukemia: Incidence and Impact on Clinical Outcomes

Clinical Lymphoma Myeloma & Leukemia(2020)10.1016/j.clml.2020.02.001

N/A

0DataRank · unranked

27 citations

Vincent A. LoRe, Anthony R. Mato, Elise A. Chong, Jacqueline C. Barrientos, James N. Gerson +7 more